September has a reputation problem, and this year it comes with receipts. The Fed’s next rate decision lands on September 16, the CPI print drops September 11, and both are exactly the kind of macro catalyst that can move the entire market regardless of how carefully you picked your individual names. I’m not going to pretend I can hand you five stocks immune to a market-wide selloff, because that stock doesn’t exist. What I can do is build a list specifically engineered to avoid the other kind of disaster, the single-stock black swan, the earnings surprise, the legal landmine, the concentrated bet on a story that unravels overnight. This list prioritizes win rate over upside. If you wanted five names that could double, this isn’t that article.
Due to space constraints, I cannot list all the indicators and strategies that I have focused on below, so the article only introduces common and familiar parameters. In our own quant rating tool, you can find real-time rating data, which is more objective and the selected strategies and indicators are more comprehensive.
The Screening Logic Before the Picks
Every name on this list had to clear four specific filters.
- No earnings report scheduled during September, since a surprise quarterly miss is the single most common trigger for an individual stock crashing 10% or more in a single session.
- A beta meaningfully below 1.0, meaning the stock historically moves less violently than the broader market in both directions.
- A business model insulated from a single product cycle or a single customer concentration risk.
- Wherever possible, a recently resolved overhang rather than an open one, since a cleared legal settlement or a stabilized guidance cut is a genuinely different risk profile than an unresolved question mark hanging over the stock.
Berkshire Hathaway (BRK.B) — The Mega-Cap Anchor
Berkshire closed at $504.91 on August 26, trading with a beta of just 0.60 and a trailing P/E of 12.68, sitting comfortably in the middle of its 52-week range of $464.01 to $537.74 and above its 200-day moving average. The single most important data point for this list specifically is the earnings date: Berkshire’s next report isn’t estimated until November 7, putting the entire month of September outside any single-day earnings risk window.
What actually makes this a win-rate pick rather than just a low-beta placeholder is the diversification baked into the business itself. You’re not betting on one product line or one customer base. Insurance underwriting through GEICO, freight rail through BNSF, utilities through Berkshire Hathaway Energy, and a public equity portfolio that Greg Abel’s team has been actively reshaping, recently adding a $10 billion Alphabet position purchased directly from the company, all sit under one ticker. A single bad news cycle in any one segment gets absorbed by the others in a way that a single-industry stock simply can’t replicate.
NextEra Energy (NEE) — The Large-Cap Utility Play
NextEra trades with a beta of 0.65, a market cap of roughly $175.7 billion, and a trailing P/E around 18.8 to 18.9 times earnings, below the broader US market average. The utility sector exists on this list precisely because it’s structurally the most insulated from discretionary consumer spending swings, and NextEra’s Q2 2026 results, reported July 24, already came in with adjusted EPS up 9.5% to 9.8% year over year, comfortably clearing the bar before September even begins. Estimated next earnings sit around October 26, again safely outside the window.
There’s a real dividend catalyst sitting inside September specifically: NextEra’s board declared a $0.6232 quarterly dividend with an ex-date of August 28 and a payment date of September 15, landing directly during the month this list covers. The stock has outpaced its utility peers with a 12.6% gain over the trailing year, and the pending Dominion Energy merger, while a longer-dated story, adds a structural growth angle without introducing near-term event risk.
Johnson & Johnson (JNJ) — The Lowest-Beta Name on the List
Johnson & Johnson carries a beta of just 0.26, making it the single most defensively positioned stock in this entire group, trading around $266 to $270 with a market cap near $632 to $643 billion. This is a 64-consecutive-year dividend increaser, a streak that survives recessions, rate hikes, and sector rotations essentially by design.
The reason JNJ earns a spot here right now specifically, rather than at any other point in its history, is that a major overhang just got resolved rather than sitting open and unpredictable. The company reached a talc-related settlement worth at least $5.5 billion, closing out years of litigation uncertainty that had been weighing on sentiment. A cleared legal liability is a fundamentally different risk profile than a pending one, and combined with recent FDA approval for Imaavy and continued strength in oncology through Darzalex and Carvykti, this is a business with genuine pipeline momentum and one less unpredictable variable hanging over it heading into a volatile macro month.
Walmart (WMT) — The Contrarian Bad-News-Is-Already-Priced-In Pick
This one requires an explanation, because on the surface a stock that just fell roughly 9% doesn’t sound like a low-volatility idea. Walmart reported Q2 earnings on August 21, actually beating on EPS, $0.81 against a $0.74 estimate, while shares dropped sharply on margin quality concerns and softer comparable sales growth. Oppenheimer has since described a bottoming range in the low $90s to low $100s, and the next earnings report isn’t estimated until November 18 or 19, meaning the entire month of September sits in a news vacuum after the selloff rather than ahead of an unknown catalyst.
I’m including Walmart specifically because “avoid black swans” and “buy the stock right before its news event” are opposite strategies, and Walmart just had its news event. Beta sits at 0.60, the dividend aristocrat status remains intact, and with the worst-case scenario already reflected in the price and no fresh earnings catalyst until well past September, this is closer to a stock that has already absorbed its shock than one still waiting to deliver it.
Church & Dwight (CHD) — The Mid-Cap Technical and Defensive Setup
Rounding out the list with genuine market-cap diversification, Church & Dwight was specifically flagged by CNBC technical strategist Katie Stockton on August 3 as an attractive, low-beta consumer staples standout heading into what she explicitly described as a potentially volatile third quarter. The stock cleared resistance from its weekly cloud model, marking a new cyclical uptrend, with the 200-day moving average sitting near $93 as a defined risk-management floor and resistance levels at $106 and then $114 above that.
Yes, some analysts have trimmed fair value estimates modestly, from around $120 down to $114, citing a softer consumer backdrop across the staples sector broadly. But that’s precisely the kind of already-priced-in caution that supports a win-rate thesis rather than undermines it, a stock isn’t a black-swan risk simply because analysts have already adjusted expectations downward; the actual danger sits in stocks where expectations haven’t been adjusted yet.
How to Verify Every One of These Picks Yourself
I don’t want you taking any of this on faith, mine or anyone else’s. Open free Stock Quant Rating tool and run each of these five tickers individually. The composite score breaks each stock down across 22 factors spread over six categories, and because this list is explicitly built around minimizing downside rather than maximizing upside, I’d specifically recommend adjusting the default equal weighting before you look at the results: increase the weight on Profitability and Financial Health and Valuation, and reduce Momentum and Sentiment. That configuration deliberately de-emphasizes short-term price chasing and analyst hype, and instead surfaces whether the underlying balance sheet and earnings quality actually support the defensive thesis each of these five names is being included for.
Check the Volatility factor specifically inside the Trading Activity category for each ticker, since it’s calculated directly off beta and will let you confirm independently that Berkshire, NextEra, Johnson & Johnson, Walmart, and Church & Dwight actually score the way this article claims before you commit real capital to any of them.
The Honest Caveat
None of this eliminates September 16 and September 11 as real, scheduled, market-wide risk events. A sufficiently hawkish Fed statement or a hot CPI print can drag every stock on this list lower for a session or two regardless of how clean the underlying fundamentals are, and I’m not going to pretend otherwise. What this list is actually built to avoid is the second layer of risk, the company-specific disaster that has nothing to do with the Fed and everything to do with a surprise earnings miss, an unresolved lawsuit, or a concentrated bet on a single product cycle. Five stocks, five different corners of the market, zero September earnings dates between them, and a beta profile that should, on a normal trading day, move considerably less than the index itself in either direction.